Shuenn-Chen Yang - Concepedia

Author

Shuenn-Chen Yang

Institute of Biomedical Sciences, Academia Sinica

Also Known As

SHUENN-CHEN YANG, Shuenn-Chen Yang

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Institute of Biomedical Sciences, Academia Sinica National Taiwan University National Cheng Kung University National Taiwan University Hospital China Medical University

About

Shuenn-Chen Yang is an author at Institute of Biomedical Sciences, Academia Sinica specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	114
2	Engineering	1	1	43
3	Natural Sciences	1	1	13
4	Biochemistry	1	1	13
5	Biomedical Engineering	1	1	43

Shuenn-Chen Yang

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line Yi-Wen Chu, Pan‐Chyr Yang, Shuenn-Chen Yang, American Journal of Respiratory Cell and Molecular Biology	1997	424
Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer Chi‐Tai Yeh, Alexander T.H. Wu, Peter Mu‐Hsin Chang, American Journal of Respiratory and Critical Care Medicine	2012	214
Transcription Repressor<i>Slug</i>Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma Jin‐Yuan Shih, Meng-Feng Tsai, Tzu-Hua Chang, Clinical Cancer Research	2005	205
Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer Tse‐Ming Hong, Yuh-Ling Chen, Yi-Ying Wu, Clinical Cancer Research	2007	197
Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma Yu-Chih Chao, Szu‐Hua Pan, Shuenn-Chen Yang, American Journal of Respiratory and Critical Care Medicine	2008	171
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis Ching-Wen Lin, Lu-Kai Wang, Shu‐Ping Wang, Nature Communications	2016	89
The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens Yi-Ying Wu, Hung-Chang Wu, Jia-En Wu, Journal of Experimental & Clinical Cancer Research	2019	59
Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues as Potent Cytotoxic Agents Xiaoming Yang, Qian Shi, Yi-Nan Liu, Journal of Medicinal Chemistry	2009	47
Extracellular delivery of modified oligonucleotide and superparamagnetic iron oxide nanoparticles from a degradable hydrogel triggered by tumor acidosis Ching-Wen Lin, S.‐Ja Tseng, Ivan M. Kempson, Biomaterials NanoparticlesNanomedicineDegradable HydrogelBiocompatible MaterialEngineering	2013	43
Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues as Potent and Selective Antitumor Agents Xiaoming Yang, Qian Shi, Shuenn-Chen Yang, Journal of Medicinal Chemistry	2011	40

Page 1